Structural determinants governing β-arrestin2 interaction with PDZ proteins and recruitment to CRFR1

Area of Science:

• Molecular biology
• Neuroscience
• Cell biology

Background:

• Beta-arrestins (β-arrestins) are crucial adaptor proteins regulating G protein-coupled receptor (GPCR) trafficking and signaling.
• Corticotropin-releasing factor receptor 1 (CRFR1) is a GPCR targeted by antagonists with anxiolytic and antidepressant effects.
• PDZ proteins are known modulators of β-arrestin2 recruitment and CRFR1 internalization.

Purpose of the Study:

• To structurally characterize the interaction between β-arrestins and PDZ proteins.
• To understand the PDZ-dependent regulation mechanisms of GPCR trafficking.
• To identify potential therapeutic targets for CRFR1 signaling in psychiatric disorders.

Main Methods:

• Investigated interactions between β-arrestin2 and PDZ proteins (PSD-95, MAGI1, PDZK1) using domain-dependent assays.
• Performed mutational analyses on β-arrestin2, specifically the A175F mutation.
• Assessed CRF-stimulated recruitment to CRFR1 and receptor internalization using the mutant β-arrestin2.

Main Results:

• PSD-95, MAGI1, and PDZK1 interact with β-arrestin2 in a PDZ domain-dependent manner.
• Mutation of alanine at residue 175 (A175F) in β-arrestin2 impaired its interaction with PSD-95.
• The A175F mutant exhibited decreased CRF-stimulated recruitment to CRFR1 and reduced receptor internalization.

Conclusions:

• The interaction between β-arrestins and PDZ proteins is essential for CRFR1 trafficking.
• Targeting the β-arrestin-PDZ protein interaction may offer a strategy to modulate CRFR1 signaling.
• This interaction holds potential for treating mental and psychiatric disorders associated with impaired CRFR1 signaling.